These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 35073341)

  • 1. Mutually exclusive mutation profiles define functionally related genes in muscle invasive bladder cancer.
    Sangster AG; Gooding RJ; Garven A; Ghaedi H; Berman DM; Davey SK
    PLoS One; 2022; 17(1):e0259992. PubMed ID: 35073341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic Alterations in the Molecular Subtypes of Bladder Cancer: Illustration in the Cancer Genome Atlas Dataset.
    Choi W; Ochoa A; McConkey DJ; Aine M; Höglund M; Kim WY; Real FX; Kiltie AE; Milsom I; Dyrskjøt L; Lerner SP
    Eur Urol; 2017 Sep; 72(3):354-365. PubMed ID: 28365159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Muscle-invasive Urothelial Cancer: Association of Mutational Status with Metastatic Pattern and Survival.
    Alessandrino F; Williams K; Nassar AH; Gujrathi R; Silverman SG; Sonpavde G; Shinagare AB
    Radiology; 2020 Jun; 295(3):572-580. PubMed ID: 32228295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RB1 and TP53 co-mutations correlate strongly with genomic biomarkers of response to immunity checkpoint inhibitors in urothelial bladder cancer.
    Manzano RG; Catalan-Latorre A; Brugarolas A
    BMC Cancer; 2021 Apr; 21(1):432. PubMed ID: 33879103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Modeling Approach to Explain Mutually Exclusive and Co-Occurring Genetic Alterations in Bladder Tumorigenesis.
    Remy E; Rebouissou S; Chaouiya C; Zinovyev A; Radvanyi F; Calzone L
    Cancer Res; 2015 Oct; 75(19):4042-52. PubMed ID: 26238783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular alterations in retinoblastoma beyond RB1.
    Mendonça V; Evangelista AC; P Matta B; M Moreira MÂ; Faria P; Lucena E; Seuánez HN
    Exp Eye Res; 2021 Oct; 211():108753. PubMed ID: 34478740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromatin-regulatory genes served as potential therapeutic targets for patients with urothelial bladder carcinoma.
    Qiu JG; Shi DY; Liu X; Zheng XX; Wang L; Li Q
    J Cell Physiol; 2019 May; 234(5):6976-6982. PubMed ID: 30317582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of KDM6A mutation in bladder cancer immune escape.
    Chen X; Lin X; Pang G; Deng J; Xie Q; Zhang Z
    BMC Cancer; 2021 May; 21(1):635. PubMed ID: 34051747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the role of mutations in the KMT2D histone lysine methyltransferase in bladder cancer.
    Ding B; Yan L; Zhang Y; Wang Z; Zhang Y; Xia D; Ye Z; Xu H
    FEBS Open Bio; 2019 Apr; 9(4):693-706. PubMed ID: 30984543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SIU-ICUD consultation on bladder cancer: basic science.
    McConkey DJ; Lerner SP
    World J Urol; 2019 Jan; 37(1):15-29. PubMed ID: 30547196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of KMT2D and KDM6A mutations by exome sequencing in Korean patients with Kabuki syndrome.
    Cheon CK; Sohn YB; Ko JM; Lee YJ; Song JS; Moon JW; Yang BK; Ha IS; Bae EJ; Jin HS; Jeong SY
    J Hum Genet; 2014 Jun; 59(6):321-5. PubMed ID: 24739679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pan-cancer molecular analysis of the RB tumor suppressor pathway.
    Knudsen ES; Nambiar R; Rosario SR; Smiraglia DJ; Goodrich DW; Witkiewicz AK
    Commun Biol; 2020 Apr; 3(1):158. PubMed ID: 32242058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concurrent alterations in TERT, KDM6A, and the BRCA pathway in bladder cancer.
    Nickerson ML; Dancik GM; Im KM; Edwards MG; Turan S; Brown J; Ruiz-Rodriguez C; Owens C; Costello JC; Guo G; Tsang SX; Li Y; Zhou Q; Cai Z; Moore LE; Lucia MS; Dean M; Theodorescu D
    Clin Cancer Res; 2014 Sep; 20(18):4935-48. PubMed ID: 25225064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kabuki syndrome genes KMT2D and KDM6A: functional analyses demonstrate critical roles in craniofacial, heart and brain development.
    Van Laarhoven PM; Neitzel LR; Quintana AM; Geiger EA; Zackai EH; Clouthier DE; Artinger KB; Ming JE; Shaikh TH
    Hum Mol Genet; 2015 Aug; 24(15):4443-53. PubMed ID: 25972376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic Subtypes of Non-invasive Bladder Cancer with Distinct Metabolic Profile and Female Gender Bias in KDM6A Mutation Frequency.
    Hurst CD; Alder O; Platt FM; Droop A; Stead LF; Burns JE; Burghel GJ; Jain S; Klimczak LJ; Lindsay H; Roulson JA; Taylor CF; Thygesen H; Cameron AJ; Ridley AJ; Mott HR; Gordenin DA; Knowles MA
    Cancer Cell; 2017 Nov; 32(5):701-715.e7. PubMed ID: 29136510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutation Update for Kabuki Syndrome Genes KMT2D and KDM6A and Further Delineation of X-Linked Kabuki Syndrome Subtype 2.
    Bögershausen N; Gatinois V; Riehmer V; Kayserili H; Becker J; Thoenes M; Simsek-Kiper PÖ; Barat-Houari M; Elcioglu NH; Wieczorek D; Tinschert S; Sarrabay G; Strom TM; Fabre A; Baynam G; Sanchez E; Nürnberg G; Altunoglu U; Capri Y; Isidor B; Lacombe D; Corsini C; Cormier-Daire V; Sanlaville D; Giuliano F; Le Quan Sang KH; Kayirangwa H; Nürnberg P; Meitinger T; Boduroglu K; Zoll B; Lyonnet S; Tzschach A; Verloes A; Di Donato N; Touitou I; Netzer C; Li Y; Geneviève D; Yigit G; Wollnik B
    Hum Mutat; 2016 Sep; 37(9):847-64. PubMed ID: 27302555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular landscape of carcinoma invading bladder muscle: does patient age matter?
    Seiler R; Wyatt AW; Black PC
    BJU Int; 2019 Nov; 124(5):719-721. PubMed ID: 31074172
    [No Abstract]   [Full Text] [Related]  

  • 18. Macroscopic somatic clonal expansion in morphologically normal human urothelium.
    Li R; Du Y; Chen Z; Xu D; Lin T; Jin S; Wang G; Liu Z; Lu M; Chen X; Xu T; Bai F
    Science; 2020 Oct; 370(6512):82-89. PubMed ID: 33004515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant patterns of H3K4 and H3K27 histone lysine methylation occur across subgroups in medulloblastoma.
    Dubuc AM; Remke M; Korshunov A; Northcott PA; Zhan SH; Mendez-Lago M; Kool M; Jones DT; Unterberger A; Morrissy AS; Shih D; Peacock J; Ramaswamy V; Rolider A; Wang X; Witt H; Hielscher T; Hawkins C; Vibhakar R; Croul S; Rutka JT; Weiss WA; Jones SJ; Eberhart CG; Marra MA; Pfister SM; Taylor MD
    Acta Neuropathol; 2013 Mar; 125(3):373-84. PubMed ID: 23184418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promoter hypermethylation of the 14-3-3 sigma, SYK and CAGE-1 genes is related to the various phenotypes of urinary bladder carcinomas and associated with progression of transitional cell carcinomas.
    Kunze E; Wendt M; Schlott T
    Int J Mol Med; 2006 Oct; 18(4):547-57. PubMed ID: 16964403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.